Combined Effect of Bicarbonate and Insulin with Glucose in Acute Therapy of Hyperkalemia in End-Stage Renal Disease Patients
The DOI matches its Crossref record.
Abstract
This study was performed to evaluate the efficacy of various treatment modalities for hyperkalemia in 8 end-stage renal disease (ESRD) patients. Simultaneous administration of sodium bicarbonate and insulin with glucose was compared with infusion of either bicarbonate alone or insulin and glucose. Plasma potassium was measured at the baseline and after 60 min of infusion with each regimen. Infusion of 8.4% solution of sodium bicarbonate at 2 mEq/min for 60 min induced a significant rise in blood bicarbonate from 21.7 +/- 2.1 to 26.3 +/- 1.7 mEq/l (p < 0.01), but failed to lower plasma potassium (6.4 +/- 0.1 vs. 6.3 +/- 0.2 mEq/l, before and after). Intravenous infusion of insulin and glucose (5 mU/kg/min for 60 min) significantly lowered plasma potassium from 6.3 +/- 0.1 to 5.7 +/- 0.1 mEq/l (p < 0.01). The combined infusion of bicarbonate and insulin with glucose showed the greatest decline in plasma potassium, from 6.2 +/- 0.2 to 5.2 +/- 0.1 mEq/l (p < 0.01). With the combined regimen, the increases in plasma bicarbonate (22.3 +/- 1.7 to 25.8 +/- 1.9 mEq/l, p < 0.05) and blood pH (7.36 +/- 0.02 to 7.42 +/- 0.02, p < 0.01) were significant, but somewhat less than those with bicarbonate administration alone. Plasma insulin levels before treatment were similar in all treatment regimens, and increased markedly following the infusion of insulin with glucose, either with or without sodium bicarbonate (9 +/- 1.5 vs. 10 +/- 10 microU/ml before insulin, and 196 +/- 18.0 vs. 201 +/- 26.4 microU/ml after insulin). Plasma epinephrine, norepinephrine, osmolality and plasma aldosterone before and after treatment did not show any significant differences among the 3 different regimens. In conclusion, the ineffectiveness of sodium bicarbonate alone and its synergistic effect with insulin and glucose in acute therapy of hyperkalemia in ESRD patients suggest that mild metabolic acidosis, which is common in patients on maintenance hemodialysis, may contribute to tissue insensitivity to the action of insulin on transcellular potassium shift.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Management of severe hyperkalemia
Weisberg, L. S. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818f222b · Cited by 268
Incidence of hypoglycemia following insulin-based acute stabilization of hyperkalemia treatment
Schafers, S., Naunheim, R., Vijayan, A., & Tobin, G. (2012) · Journal of Hospital Medicine · doi:10.1002/jhm.977 · Cited by 70
Pierce, D. A., Russell, G., & Pirkle, J. L. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015607559 · Cited by 48
Impact of dextrose dose on hypoglycemia development following treatment of hyperkalemia
Farina, N., & Anderson, C. (2018) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098618768725 · Cited by 30
Metadata
- Authors
- Kim, H.-J.
- Venue
- Nephron
- Publisher
- S. Karger AG
- Published
- 1996
- Volume
- 72
- Issue
- 3
- Pages
- 476-482
- ISSN
- 1660-8151 (ISSN-L)
- 2235-3186
- OpenAlex
- W2011978785
- Cited by
- 83
- References
- 0
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Combined Effect of Bicarbonate and Insulin with Glucose in Acute Therapy of Hyperkalemia in End-Stage Renal Disease Patients. https://app.cochat.ai/papers/10.1159/000188917
- The paper
- Kim, H.-J. (1996). Combined Effect of Bicarbonate and Insulin with Glucose in Acute Therapy of Hyperkalemia in End-Stage Renal Disease Patients. Nephron. https://doi.org/10.1159/000188917
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.